Perioperative steroid use in colorectal patients
Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned....
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1996 |
|---|
| Umfang: |
5 |
|---|
| Reproduktion: |
Springer Online Journal Archives 1860-2002 |
|---|---|
| Übergeordnetes Werk: |
in: Diseases of the colon & rectum - 1990, 39(1996) vom: Sept., Seite 995-999 |
| Übergeordnetes Werk: |
volume:39 ; year:1996 ; month:09 ; pages:995-999 ; extent:5 |
| Links: |
|---|
| Katalog-ID: |
NLEJ207519919 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ207519919 | ||
| 003 | DE-627 | ||
| 005 | 20230506084018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 070528s1996 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)NLEJ207519919 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Perioperative steroid use in colorectal patients |
| 264 | 1 | |c 1996 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. | ||
| 533 | |f Springer Online Journal Archives 1860-2002 | ||
| 700 | 1 | |a Beck, David E. |4 oth | |
| 700 | 1 | |a Opelka, Frank G. |4 oth | |
| 773 | 0 | 8 | |i in |t Diseases of the colon & rectum |d 1990 |g 39(1996) vom: Sept., Seite 995-999 |w (DE-627)NLEJ188993568 |w (DE-600)2046914-7 |x 1530-0358 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:1996 |g month:09 |g pages:995-999 |g extent:5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/BF02054688 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-SOJ | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 1996 |c 9 |h 995-999 |g 5 | ||
| matchkey_str |
article:15300358:1996----::eiprtvseodsiclr |
|---|---|
| hierarchy_sort_str |
1996 |
| publishDate |
1996 |
| allfields |
(DE-627)NLEJ207519919 DE-627 ger DE-627 rakwb eng Perioperative steroid use in colorectal patients 1996 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. Springer Online Journal Archives 1860-2002 Beck, David E. oth Opelka, Frank G. oth in Diseases of the colon & rectum 1990 39(1996) vom: Sept., Seite 995-999 (DE-627)NLEJ188993568 (DE-600)2046914-7 1530-0358 nnns volume:39 year:1996 month:09 pages:995-999 extent:5 http://dx.doi.org/10.1007/BF02054688 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 39 1996 9 995-999 5 |
| spelling |
(DE-627)NLEJ207519919 DE-627 ger DE-627 rakwb eng Perioperative steroid use in colorectal patients 1996 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. Springer Online Journal Archives 1860-2002 Beck, David E. oth Opelka, Frank G. oth in Diseases of the colon & rectum 1990 39(1996) vom: Sept., Seite 995-999 (DE-627)NLEJ188993568 (DE-600)2046914-7 1530-0358 nnns volume:39 year:1996 month:09 pages:995-999 extent:5 http://dx.doi.org/10.1007/BF02054688 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 39 1996 9 995-999 5 |
| allfields_unstemmed |
(DE-627)NLEJ207519919 DE-627 ger DE-627 rakwb eng Perioperative steroid use in colorectal patients 1996 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. Springer Online Journal Archives 1860-2002 Beck, David E. oth Opelka, Frank G. oth in Diseases of the colon & rectum 1990 39(1996) vom: Sept., Seite 995-999 (DE-627)NLEJ188993568 (DE-600)2046914-7 1530-0358 nnns volume:39 year:1996 month:09 pages:995-999 extent:5 http://dx.doi.org/10.1007/BF02054688 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 39 1996 9 995-999 5 |
| allfieldsGer |
(DE-627)NLEJ207519919 DE-627 ger DE-627 rakwb eng Perioperative steroid use in colorectal patients 1996 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. Springer Online Journal Archives 1860-2002 Beck, David E. oth Opelka, Frank G. oth in Diseases of the colon & rectum 1990 39(1996) vom: Sept., Seite 995-999 (DE-627)NLEJ188993568 (DE-600)2046914-7 1530-0358 nnns volume:39 year:1996 month:09 pages:995-999 extent:5 http://dx.doi.org/10.1007/BF02054688 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 39 1996 9 995-999 5 |
| allfieldsSound |
(DE-627)NLEJ207519919 DE-627 ger DE-627 rakwb eng Perioperative steroid use in colorectal patients 1996 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. Springer Online Journal Archives 1860-2002 Beck, David E. oth Opelka, Frank G. oth in Diseases of the colon & rectum 1990 39(1996) vom: Sept., Seite 995-999 (DE-627)NLEJ188993568 (DE-600)2046914-7 1530-0358 nnns volume:39 year:1996 month:09 pages:995-999 extent:5 http://dx.doi.org/10.1007/BF02054688 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 39 1996 9 995-999 5 |
| language |
English |
| source |
in Diseases of the colon & rectum 39(1996) vom: Sept., Seite 995-999 volume:39 year:1996 month:09 pages:995-999 extent:5 |
| sourceStr |
in Diseases of the colon & rectum 39(1996) vom: Sept., Seite 995-999 volume:39 year:1996 month:09 pages:995-999 extent:5 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Diseases of the colon & rectum |
| authorswithroles_txt_mv |
Beck, David E. @@oth@@ Opelka, Frank G. @@oth@@ |
| publishDateDaySort_date |
1996-09-01T00:00:00Z |
| hierarchy_top_id |
NLEJ188993568 |
| id |
NLEJ207519919 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ207519919</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506084018.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1996 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ207519919</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Perioperative steroid use in colorectal patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beck, David E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Opelka, Frank G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Diseases of the colon & rectum</subfield><subfield code="d">1990</subfield><subfield code="g">39(1996) vom: Sept., Seite 995-999</subfield><subfield code="w">(DE-627)NLEJ188993568</subfield><subfield code="w">(DE-600)2046914-7</subfield><subfield code="x">1530-0358</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1996</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:995-999</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02054688</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1996</subfield><subfield code="c">9</subfield><subfield code="h">995-999</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| series2 |
Springer Online Journal Archives 1860-2002 |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ188993568 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1530-0358 |
| topic_title |
Perioperative steroid use in colorectal patients |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d e b de deb f g o fg fgo |
| hierarchy_parent_title |
Diseases of the colon & rectum |
| hierarchy_parent_id |
NLEJ188993568 |
| hierarchy_top_title |
Diseases of the colon & rectum |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ188993568 (DE-600)2046914-7 |
| title |
Perioperative steroid use in colorectal patients |
| spellingShingle |
Perioperative steroid use in colorectal patients |
| ctrlnum |
(DE-627)NLEJ207519919 |
| title_full |
Perioperative steroid use in colorectal patients |
| journal |
Diseases of the colon & rectum |
| journalStr |
Diseases of the colon & rectum |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1996 |
| contenttype_str_mv |
zzz |
| container_start_page |
995 |
| container_volume |
39 |
| physical |
5 |
| format_se |
Elektronische Aufsätze |
| title_sort |
perioperative steroid use in colorectal patients |
| title_auth |
Perioperative steroid use in colorectal patients |
| abstract |
Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. |
| abstractGer |
Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. |
| abstract_unstemmed |
Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent. |
| collection_details |
GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE |
| title_short |
Perioperative steroid use in colorectal patients |
| url |
http://dx.doi.org/10.1007/BF02054688 |
| remote_bool |
true |
| author2 |
Beck, David E. Opelka, Frank G. |
| author2Str |
Beck, David E. Opelka, Frank G. |
| ppnlink |
NLEJ188993568 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| up_date |
2024-07-06T09:54:22.747Z |
| _version_ |
1803822996124598272 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ207519919</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506084018.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1996 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ207519919</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Perioperative steroid use in colorectal patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract PURPOSE: A survey was conducted to document current perioperative steroid use in colorectal patients. METHODS: A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons. RESULTS: Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents). CONCLUSION: Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beck, David E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Opelka, Frank G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Diseases of the colon & rectum</subfield><subfield code="d">1990</subfield><subfield code="g">39(1996) vom: Sept., Seite 995-999</subfield><subfield code="w">(DE-627)NLEJ188993568</subfield><subfield code="w">(DE-600)2046914-7</subfield><subfield code="x">1530-0358</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1996</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:995-999</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02054688</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1996</subfield><subfield code="c">9</subfield><subfield code="h">995-999</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.402237 |